Insider Selling: Maximus (NYSE:MMS) Insider Sells 1,610 Shares of Stock

Key Points

• Maximus insider Michelle Link sold 1,610 shares of the company's stock at an average price of $90.86, decreasing their holdings by 10.65%.
• The company reported earnings of $2.16 EPS for the last quarter, exceeding analysts' estimates and marking a 2.5% revenue increase compared to the previous year.
• Maximus recently announced a quarterly dividend of $0.30, resulting in an annualized yield of 1.3% and a payout ratio of 22.1%.

Maximus, Inc. (NYSE:MMS - Get Free Report) insider Michelle Link sold 1,610 shares of the company's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider directly owned 13,508 shares in the company, valued at $1,227,336.88. The trade was a 10.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Maximus Stock Performance

NYSE MMS traded up $0.42 on Thursday, reaching $91.29. The stock had a trading volume of 516,999 shares, compared to its average volume of 576,455. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The company has a market cap of $5.14 billion, a P/E ratio of 16.81 and a beta of 0.57. The firm has a fifty day moving average of $84.35 and a two-hundred day moving average of $75.02. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.73.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the firm earned $1.74 earnings per share. Maximus's revenue for the quarter was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Sunday, August 31st. Shareholders of record on Friday, August 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend was Friday, August 15th. Maximus's dividend payout ratio (DPR) is currently 22.10%.

Hedge Funds Weigh In On Maximus

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Fuller & Thaler Asset Management Inc. increased its holdings in shares of Maximus by 40.0% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock worth $117,921,000 after buying an additional 494,372 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Maximus by 20.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider's stock valued at $115,620,000 after purchasing an additional 288,990 shares in the last quarter. Van Berkom & Associates Inc. grew its holdings in shares of Maximus by 1.5% during the first quarter. Van Berkom & Associates Inc. now owns 1,275,394 shares of the health services provider's stock worth $86,969,000 after purchasing an additional 18,976 shares during the last quarter. AQR Capital Management LLC raised its holdings in Maximus by 177.2% in the 1st quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider's stock valued at $79,341,000 after buying an additional 750,031 shares during the last quarter. Finally, Reinhart Partners LLC. grew its holdings in Maximus by 0.3% during the 2nd quarter. Reinhart Partners LLC. now owns 913,856 shares of the health services provider's stock worth $64,154,000 after acquiring an additional 2,345 shares during the last quarter. Institutional investors own 97.21% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Strong Buy" and an average price target of $90.00.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.